Moleculin Biotech Inc [NASDAQ: MBRX] jumped around 0.22 points on Tuesday, while shares priced at $1.29 at the close of the session, up 20.56%.
Compared to the average trading volume of 4.68M shares, MBRX reached a trading volume of 39302913 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Moleculin Biotech Inc [MBRX]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for MBRX shares is $28.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on MBRX stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Maxim Group have made an estimate for Moleculin Biotech Inc shares, keeping their opinion on the stock as Hold, with their previous recommendation back on February 12, 2025. While these analysts kept the previous recommendation, Oppenheimer raised their target price to Outperform. The new note on the price target was released on July 18, 2022, representing the official price target for Moleculin Biotech Inc stock.
The Average True Range (ATR) for Moleculin Biotech Inc is set at 0.45 The Price to Book ratio for the last quarter was 0.52, with the Price to Cash per share for the same quarter was set at 2.26.
How has MBRX stock performed recently?
Moleculin Biotech Inc [MBRX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -32.81. With this latest performance, MBRX shares dropped by -24.12% in over the last four-week period, additionally sinking by -46.69% over the last 6 months – not to mention a drop of -83.30% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MBRX stock in for the last two-week period is set at 47.78, with the RSI for the last a single of trading hit 48.79, and the three-weeks RSI is set at 46.73 for Moleculin Biotech Inc [MBRX]. The present Moving Average for the last 50 days of trading for this stock 1.6165, while it was recorded at 1.3620 for the last single week of trading, and 2.7629 for the last 200 days.
Moleculin Biotech Inc [MBRX]: Deeper insight into the fundamentals
Moleculin Biotech Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.08 and a Current Ratio set at 2.08.
Earnings analysis for Moleculin Biotech Inc [MBRX]
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for MBRX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Moleculin Biotech Inc go to 36.38%.
